Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shields, M. J.
Right arrow Articles by Ribaudo, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shields, M. J.
Right arrow Articles by Ribaudo, R. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 43, 28010-28018, October 23, 1998

The Effect of Human beta 2-Microglobulin on Major Histocompatibility Complex I Peptide Loading and the Engineering of a High Affinity Variant
IMPLICATIONS FOR PEPTIDE-BASED VACCINES

Michael J. ShieldsDagger , Ryuji Kubota, Wesley HodgsonDagger , Steven Jacobson, William E. Biddison, and Randall K. RibaudoDagger

From the Dagger  Laboratory of Immune Cell Biology, NCI, National Institutes of Health, Bethesda, Maryland 20892-1152 and the  Neuroimmunology Branch, NINDS, National Institutes of Health, Bethesda, Maryland 20892

The ability to directly load cell surface major histocompatibility complex (MHC) class I molecules with peptides provides a potentially powerful approach toward the development of vaccines to generate cell-mediated immunity. We demonstrate that exogenous beta 2-microglobulin (beta 2m) stabilizes human cell surface MHC I molecules and facilitates their loading with exogenous peptides. Additionally, using three-dimensional crystal structures and known interaction sites between MHC I heavy chains and beta 2m, we engineered variants of human beta 2m (hbeta 2m) with a single serine substitution at residue 55. This alteration was predicted to promote hydrophobic interactions at the MHC I heavy chain/beta 2m interface and displace an ordered water molecule. Compared with hbeta 2m, the serine to valine substitution at residue 55 had improved ability to bind to cell surface HLA-A1, HLA-A2, and HLA-A3 molecules, facilitate exogenous peptide loading, and promote recognition by peptide-specific T cells. The inclusion of hbeta 2m or higher affinity variants when pulsing cells with MHC-restricted peptides increases the efficiency of peptide loading 50-80-fold. Therefore, the inclusion of hbeta 2m in peptide-based vaccines may increase cell surface antigen densities above thresholds that allow recognition of peptide antigens by the immune system, particularly for cryptic, subdominant, or marginally antigenic peptides.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
J-E Gottenberg, M Busson, J Cohen-Solal, F Lavie, K Abbed, R P Kimberly, J Sibilia, and X Mariette
Correlation of serum B lymphocyte stimulator and {beta}2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome
Ann Rheum Dis, July 1, 2005; 64(7): 1050 - 1055.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Berko, Y. Carmi, G. Cafri, S. Ben-Zaken, H. M. Sheikhet, E. Tzehoval, L. Eisenbach, A. Margalit, and G. Gross
Membrane-Anchored {beta}2-Microglobulin Stabilizes a Highly Receptive State of MHC Class I Molecules
J. Immunol., February 15, 2005; 174(4): 2116 - 2123.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Laugel, J. M. Boulter, N. Lissin, A. Vuidepot, Y. Li, E. Gostick, L. E. Crotty, D. C. Douek, J. Hemelaar, D. A. Price, et al.
Design of Soluble Recombinant T Cell Receptors for Antigen Targeting and T Cell Inhibition
J. Biol. Chem., January 21, 2005; 280(3): 1882 - 1892.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Gidalevitz, C. Biswas, H. Ding, D. Schneidman-Duhovny, H. J. Wolfson, F. Stevens, S. Radford, and Y. Argon
Identification of the N-terminal Peptide Binding Site of Glucose-regulated Protein 94
J. Biol. Chem., April 16, 2004; 279(16): 16543 - 16552.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Hill, T. Kasliwal, E. Schwarz, A. M. Hebert, T. Chen, E. Gubina, L. Zhang, and S. Kozlowski
A Dominant Negative Mutant beta 2-Microglobulin Blocks the Extracellular Folding of a Major Histocompatibility Complex Class I Heavy Chain
J. Biol. Chem., February 14, 2003; 278(8): 5630 - 5638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Glick, D. A. Price, A.-L. Vuidepot, T. B. Andersen, S. L. Hutchinson, B. Laugel, A. K. Sewell, J. M. Boulter, P. R. Dunbar, V. Cerundolo, et al.
Novel CD8+ T Cell Antagonists Based on beta 2-Microglobulin
J. Biol. Chem., May 31, 2002; 277(23): 20840 - 20846.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Michaelsson, A. Achour, A. Rolle, and K. Karre
MHC Class I Recognition by NK Receptors in the Ly49 Family Is Strongly Influenced by the {{beta}}2-Microglobulin Subunit
J. Immunol., June 15, 2001; 166(12): 7327 - 7334.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement